Document is current

Any future updates will be listed below

The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-025-13843-4

Published Online: 2025-03-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark